epilepsy~|~hypoglycemia~|~andorra~|~behavior~|~signs and symptoms~|~and~|~and - dosing instruction fragment~|~behavior:-:point in time:^patient:-~|~epileptics~|~generalized~|~jones strain~|~relationshipconjunction - and~|~view jones~|~idiopathic epilepsy~|~general symptom
hemiplegia~|~specific qualifier value~|~lower extremity~|~affecting~|~involvement with~|~senior - suffix~|~anatomic site~|~entire lower limb~|~good~|~microplate well~|~nr4a2 gene~|~negation~|~not otherwise specified~|~side~|~site~|~specimen source codes - site~|~study site~|~well~|~well marginated nodule~|~ever told by doctor or nurse that you have high blood pressure:finding:point in time:^patient:ordinal~|~hypertensive disease
brain concussion~|~confusion~|~disorientation~|~vomiting~|~hemorrhage~|~multiple trauma~|~not otherwise specified~|~specific qualifier value~|~bothered by vomiting~|~have been vomiting~|~how much distress vomiting~|~how often vomiting~|~usual severity vomiting~|~vomiting, ctcae
tachycardia~|~abdominal pain~|~not otherwise specified~|~abdominal pain, ctcae 5~|~abdominal tenderness~|~ever told by doctor or nurse that you have high blood pressure:finding:point in time:^patient:ordinal~|~hypertensive disease
hallucinations~|~pain~|~elbow~|~nausea~|~bothered by nausea~|~elbow joint structure~|~entire elbow region~|~feel nausea~|~good~|~hallucinations, ctcae~|~have nausea~|~how much distress nausea~|~how much nausea during this period~|~how often nausea~|~medical product stability~|~microplate well~|~nr4a2 gene~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~negation~|~specific qualifier value~|~stability determination~|~stable status~|~to specify~|~usual severity nausea~|~well~|~well marginated nodule~|~administration method - pain~|~adverse event associated with pain~|~chronic - admission level of care code~|~feel pain~|~frequency of pain question~|~have pain~|~how much distress pain~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~provision of recurring care for chronic illness~|~usual severity pain~|~chronic
cardiac arrhythmia~|~chronic obstructive airway disease~|~changed status~|~changing~|~mental status, ctcae~|~mental state~|~mental status:finding:point in time:^patient:narrative:observed~|~mental status:finding:point in time:^patient:nominal:observed~|~not otherwise specified~|~adverse event associated with cardiac arrhythmia~|~external cause codes: unspecified~|~much~|~nr4a2 gene~|~negation~|~specific qualifier value~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness
abdominal pain~|~constipation~|~deglutition disorders~|~external cause codes: unspecified~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~abdomen~|~constipation, ctcae~|~have constipation~|~how much distress constipation~|~how often constipation~|~usual severity constipation~|~allergy severity - severe~|~borg category-ratio 10 perceived exertion score 5~|~dysphagia, ctcae~|~epidermal cgvhd score 4~|~gamma-delta tocotrienol~|~grade 3 severe adverse event~|~in addition to~|~intensity and distress 5~|~severe (severity modifier)~|~severe - severity of illness code~|~severe - triage code~|~severe extremity pain~|~severe hallucination~|~with - dosing instruction fragment~|~abdominal (qualifier value)~|~abdominal pain, ctcae 5
caucasoid race~|~haddock (substance)~|~haddock - dietary~|~melanogrammus aeglefinus~|~nr4a2 gene~|~negation~|~specific qualifier value~|~haddock allergenic extract~|~caucasians~|~generalized aches and pains~|~white color
changed status~|~changing~|~good~|~mental status, ctcae~|~mental state~|~mental status:finding:point in time:^patient:narrative:observed~|~mental status:finding:point in time:^patient:nominal:observed~|~microplate well~|~nr4a2 gene~|~negation~|~specific qualifier value~|~well~|~well marginated nodule
dyspnea~|~andorra~|~adult~|~specific qualifier value~|~health~|~respiration disorders~|~and~|~and - dosing instruction fragment~|~dyspnea, ctcae~|~encounter~|~external cause codes: unspecified~|~facilitated oscillatory release technique~|~healthcare encounter~|~medical product stability~|~nr4a2 gene~|~negation~|~patient visit~|~preposition for~|~relationshipconjunction - and~|~respiratory tract diseases~|~stability determination~|~stable status~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~visit~|~wwox gene~|~wwox wt allele~|~chronic - admission level of care code~|~legal adult~|~provision of recurring care for chronic illness~|~checkup examination~|~chronic
alcohol consumption~|~anxiety~|~external cause codes: unspecified~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~anxiety disorders~|~anxiety scale (basc-2)~|~anxiety visual analogue scale~|~anxiety, ctcae 3.0~|~anxiety, ctcae 5.0~|~not otherwise specified~|~restlessness and agitation~|~nausea and vomiting
wiskott-aldrich syndrome~|~membrane~|~arid1a protein, human~|~was protein, human~|~fever~|~chills~|~disease~|~highland~|~membrane device~|~tissue membrane~|~arid1a wt allele~|~chills, ctcae~|~held - activity status~|~was gene~|~washoe language~|~adult disease~|~fever symptoms (finding)~|~fever, ctcae
migraine disorders~|~headache~|~asthenia~|~external cause codes: unspecified~|~headache, ctcae~|~nr4a2 gene~|~negation~|~sostdc1 gene~|~sostdc1 wt allele~|~specific qualifier value~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness
alcohol consumption~|~alcoholic intoxication~|~allergic reaction~|~allergy specialty~|~andorra~|~external cause codes: unspecified~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~hypersensitivity~|~allergic disposition~|~allergic urticaria~|~allergy - charge type reason~|~and~|~and - dosing instruction fragment~|~in addition to~|~relationshipconjunction - and~|~response to antigens~|~specific qualifier value~|~with - dosing instruction fragment
good~|~mental status change~|~microplate well~|~nr4a2 gene~|~negation~|~specific qualifier value~|~well~|~well marginated nodule
brain~|~abnormal coordination~|~cerebral hemisphere structure (body structure)~|~specific qualifier value
dyspnea~|~hyperventilation~|~chronic obstructive airway disease~|~dyspnea, ctcae~|~external cause codes: unspecified~|~in addition to~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~with - dosing instruction fragment~|~exacerbation acute
epilepsy~|~facial injuries~|~symptoms~|~andorra~|~physical examination~|~generalized~|~diagnosis~|~and~|~and - dosing instruction fragment~|~chief complaint (finding)~|~complaint:find:pt:^patient:nom~|~diagnosis classification - diagnosis~|~diagnosis code~|~diagnosis study~|~diagnosis:impression/interpretation of study:point in time:^patient:nominal~|~examination~|~facilitated oscillatory release technique~|~in addition to~|~medical examination~|~not otherwise specified~|~preposition for~|~relationshipconjunction - and~|~report (document)~|~reported~|~reporting~|~suspected diagnosis~|~suspected qualifier~|~symptoms aspect~|~wwox gene~|~wwox wt allele~|~with - dosing instruction fragment~|~diagnosis aspect~|~general medical service~|~safety reporting documentation~|~united states military commissioned officer o10
caucasoid race~|~feeling suicidal (finding)~|~nr4a2 gene~|~negation~|~senior - suffix~|~specific qualifier value~|~caucasians~|~symptoms and signs involving emotional state~|~white color
classification~|~ask protein, human~|~intestinal obstruction~|~vomiting~|~nr4a2 gene~|~negation~|~specific qualifier value~|~activities scale for kids~|~anaplastic sarcoma of the kidney~|~dbf4 gene~|~dbf4 wt allele~|~facilitated oscillatory release technique~|~good~|~microplate well~|~preposition for~|~wwox gene~|~wwox wt allele~|~well~|~well marginated nodule~|~acute onset pain~|~bothered by vomiting~|~have been vomiting~|~how much distress vomiting~|~how often vomiting~|~pain localized to other parts of lower abdomen~|~usual severity vomiting~|~vomiting, ctcae
polyuria~|~hyperglycemia~|~signs and symptoms~|~distal (qualifier value)~|~glucose in blood specimen above reference range~|~hyperglycemia, ctcae~|~nr4a2 gene~|~negation~|~specific qualifier value~|~general symptom~|~generalized abdominal pain~|~generalized aches and pains~|~left lower quadrant pain~|~right lower quadrant pain
pain~|~epileptic syndromes~|~caucasoid race~|~epilepsy~|~andorra~|~nr4a2 gene~|~negation~|~specific qualifier value~|~and~|~and - dosing instruction fragment~|~good~|~microplate well~|~relationshipconjunction - and~|~unspecified injury of hip~|~well~|~well marginated nodule~|~idiopathic epilepsy~|~administration method - pain~|~adverse event associated with pain~|~caucasians~|~feel pain~|~frequency of pain question~|~have pain~|~how much distress pain~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~usual severity pain~|~white color
dyspnea~|~chest pain~|~chest pain on breathing~|~have shortness of breath question~|~how much distress shortness of breath~|~how often shortness of breath~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~usual severity shortness of breath~|~chest pain:finding:point in time:^patient:ordinal~|~ever told by doctor or nurse that you have high blood pressure:finding:point in time:^patient:ordinal~|~hypertensive disease
hemorrhage~|~nr4a2 gene~|~negation~|~specific qualifier value~|~andorra~|~much~|~and~|~and - dosing instruction fragment~|~distal (qualifier value)~|~encounter~|~existential restriction modifier (core metadata concept)~|~firstly~|~healthcare encounter~|~initial (abbreviation)~|~initial adverse event and product problem report~|~initial usage~|~initially~|~more~|~numerous~|~patient visit~|~relationshipconjunction - and~|~some (qualifier value)~|~traumatic~|~visit~|~generalized aches and pains~|~secondary and/or recurrent hemorrhage as early complication of trauma~|~secondary and recurrent hemorrhage
abdominal pain~|~fingers~|~hand~|~priests~|~andorra~|~hemorrhage~|~allergy severity - severe~|~and~|~and - dosing instruction fragment~|~borg category-ratio 10 perceived exertion score 5~|~entire hand~|~epidermal cgvhd score 4~|~fingers, unit of measurement~|~grade 3 severe adverse event~|~in addition to~|~intensity and distress 5~|~nr4a2 gene~|~negation~|~relationshipconjunction - and~|~sostdc1 gene~|~sostdc1 wt allele~|~severe (severity modifier)~|~severe - severity of illness code~|~severe - triage code~|~severe extremity pain~|~severe hallucination~|~specific qualifier value~|~traumatic injury~|~unspecified injury of abdomen~|~with - dosing instruction fragment~|~hand - unit of measure~|~abdominal pain, ctcae 5~|~abdominal rigidity~|~generalized aches and pains
wiskott-aldrich syndrome~|~pneumonia~|~was protein, human~|~fever~|~chills~|~chills, ctcae~|~external cause codes: unspecified~|~organism~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~was gene~|~washoe language~|~fever symptoms (finding)~|~fever, ctcae
facial injuries~|~craniocerebral trauma~|~external cause codes: unspecified~|~much~|~nr4a2 gene~|~negation~|~specific qualifier value~|~traumatic and/or non-traumatic injury~|~traumatic injury~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~unspecified injury of ankle
chest pain~|~external cause codes: unspecified~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~chest pain:finding:point in time:^patient:ordinal
ask protein, human~|~activities scale for kids~|~anaplastic sarcoma of the kidney~|~dbf4 gene~|~dbf4 wt allele~|~nr4a2 gene~|~negation~|~specific qualifier value
dizziness~|~lightheadedness~|~early complication of trauma~|~encounter~|~firstly~|~healthcare encounter~|~initial (abbreviation)~|~initial adverse event and product problem report~|~initial usage~|~initially~|~not otherwise specified~|~patient visit~|~visit~|~generalized aches and pains
specific qualifier value~|~traumatic and/or non-traumatic injury~|~traumatic injury
muscle weakness~|~paresis~|~cardiac arrhythmia~|~nausea~|~adverse event associated with cardiac arrhythmia~|~bothered by nausea~|~external cause codes: unspecified~|~feel nausea~|~have nausea~|~how much distress nausea~|~how much nausea during this period~|~how often nausea~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~usual severity nausea~|~weakness~|~chronic debility
cerebral infarction~|~aphasia~|~specific qualifier value
tremor~|~hypertensive disease~|~ever told by doctor or nurse that you have high blood pressure:finding:point in time:^patient:ordinal~|~medical product stability~|~specific qualifier value~|~stability determination~|~stable status~|~tremor, ctcae 3.0~|~tremor, ctcae 5.0~|~chronic - admission level of care code~|~provision of recurring care for chronic illness~|~chronic
wiskott-aldrich syndrome~|~was protein, human~|~fever~|~chills~|~was gene~|~washoe language~|~changed status~|~changing~|~chills, ctcae~|~mental status, ctcae~|~mental state~|~mental status:finding:point in time:^patient:narrative:observed~|~mental status:finding:point in time:^patient:nominal:observed~|~not otherwise specified~|~fever symptoms (finding)~|~fever with chills~|~fever, ctcae
chest pain~|~chest pain:finding:point in time:^patient:ordinal
headache~|~headache, ctcae
hematemesis~|~abdominal pain~|~vomiting~|~allergy severity - severe~|~borg category-ratio 10 perceived exertion score 5~|~epidermal cgvhd score 4~|~external cause codes: unspecified~|~grade 3 severe adverse event~|~in addition to~|~intensity and distress 5~|~severe (severity modifier)~|~severe - severity of illness code~|~severe - triage code~|~severe extremity pain~|~severe hallucination~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~with - dosing instruction fragment~|~abdominal pain, ctcae 5~|~abdominal rigidity~|~bothered by vomiting~|~generalized abdominal pain~|~generalized aches and pains~|~have been vomiting~|~how much distress vomiting~|~how often vomiting~|~usual severity vomiting~|~vomiting, ctcae
pain~|~body site modifier - lower~|~lane~|~lower (action)~|~lower - spatial qualifier~|~not otherwise specified~|~administration method - pain~|~adverse event associated with pain~|~feel pain~|~frequency of pain question~|~have pain~|~how much distress pain~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~usual severity pain
seizures~|~craniocerebral trauma~|~united arab emirates~|~andorra~|~fecal immunochemical test~|~fit (action)~|~fit and well~|~mass of body structure~|~prosthesis fit~|~specific qualifier value~|~and~|~and - dosing instruction fragment~|~androgen response element~|~external cause codes: unspecified~|~fbn1 gene~|~fbn1 wt allele~|~good~|~mass of body region~|~mass, a measure of quantity of matter~|~microplate well~|~molecular mass~|~morphology, attenuation, size, and structure criteria~|~nr4a2 gene~|~negation~|~relationshipconjunction - and~|~specimen source codes - mass~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~well~|~well marginated nodule~|~are unit of measure~|~localized swelling
generalized abdominal pain~|~generalized aches and pains~|~left lower quadrant pain~|~nausea or abdominal pain
back pain~|~fingers~|~andorra~|~wrist injuries~|~specific qualifier value~|~back pain, ctcae 3.0~|~back pain, ctcae 5.0~|~neck injuries~|~and~|~and - dosing instruction fragment~|~distal (qualifier value)~|~fingers, unit of measurement~|~nr4a2 gene~|~negation~|~now (cigarettes)~|~now (temporal qualifier)~|~now - dosing instruction fragment~|~relationshipconjunction - and~|~hand and wrist~|~housewife
abdominal pain~|~constipation~|~dyspnea~|~external cause codes: unspecified~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~constipation, ctcae~|~have constipation~|~how much distress constipation~|~how often constipation~|~usual severity constipation~|~dyspnea, ctcae~|~in addition to~|~with - dosing instruction fragment~|~abdominal pain, ctcae 5~|~abdominal rigidity~|~generalized abdominal pain~|~generalized aches and pains~|~severe pain
poisoning~|~andorra~|~shock~|~and~|~and - dosing instruction fragment~|~pharmaceutical preparations~|~relationshipconjunction - and~|~emotions~|~signs and symptoms~|~biological factors~|~channel~|~channel object~|~drugs - dental services~|~external cause codes: unspecified~|~feeling suicidal (finding)~|~geographic state~|~indeterminate~|~state~|~state ownership~|~stress~|~stress bismuth subsalicylate~|~us state~|~undetermined~|~undetermined finding~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~w stress
cerebral infarction~|~unconscious state~|~nr4a2 gene~|~negation~|~specific qualifier value~|~changed status~|~changing~|~external cause codes: unspecified~|~good~|~mental status, ctcae~|~mental state~|~mental status:finding:point in time:^patient:narrative:observed~|~mental status:finding:point in time:^patient:nominal:observed~|~microplate well~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~well~|~well marginated nodule~|~housewife~|~generalized aches and pains
nurse administrator~|~diazooxonorleucine~|~caucasoid race~|~forearm injuries~|~nr4a2 gene~|~negation~|~senior - suffix~|~specific qualifier value~|~to specify~|~caucasians~|~white color
syncope~|~dyspnea~|~andorra~|~dizziness~|~lightheadedness~|~disease~|~shock~|~and~|~and - dosing instruction fragment~|~relationshipconjunction - and~|~membrane~|~collapse (finding)~|~collapse (morphologic abnormality)~|~collapse of device~|~external cause codes: unspecified~|~have shortness of breath question~|~how much distress shortness of breath~|~how often shortness of breath~|~hypertension, ctcae~|~hypertensive disease~|~membrane device~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~syncope (amphibian)~|~syncope, ctcae 5.0~|~tissue membrane~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~usual severity shortness of breath~|~out (of) breath
apnea~|~apnea, ctcae~|~distal (qualifier value)~|~nr4a2 gene~|~negation~|~specific qualifier value
hyaline membrane disease~|~sambucus~|~disease~|~membrane~|~hairline~|~membrane device~|~not otherwise specified~|~senior - suffix~|~tissue membrane~|~elder extract~|~bothered by night sweats~|~night sweats
foot~|~feet, unit of measurement~|~now (cigarettes)~|~now (temporal qualifier)~|~now - dosing instruction fragment~|~specific qualifier value
abdominal pain~|~vomiting~|~in addition to~|~with - dosing instruction fragment~|~signs and symptoms~|~allergy severity - severe~|~borg category-ratio 10 perceived exertion score 5~|~emotional tenderness~|~epidermal cgvhd score 4~|~external cause codes: unspecified~|~grade 3 severe adverse event~|~intensity and distress 5~|~not otherwise specified~|~severe (severity modifier)~|~severe - severity of illness code~|~severe - triage code~|~severe extremity pain~|~severe hallucination~|~sore to touch~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~abdominal pain, ctcae 5~|~abdominal rigidity~|~bothered by vomiting~|~dominant~|~general symptom~|~generalized aches and pains~|~have been vomiting~|~how much distress vomiting~|~how often vomiting~|~usual severity vomiting~|~vomiting, ctcae
tachycardia~|~poisoning~|~andorra~|~cardiac arrhythmia~|~anxiety~|~occupations~|~and~|~and - dosing instruction fragment~|~relationshipconjunction - and~|~anxiety disorders~|~adverse event associated with cardiac arrhythmia~|~anxiety scale (basc-2)~|~anxiety visual analogue scale~|~anxiety, ctcae 3.0~|~anxiety, ctcae 5.0~|~biological factors~|~external cause codes: unspecified~|~now (cigarettes)~|~now (temporal qualifier)~|~now - dosing instruction fragment~|~pharmaceutical preparations~|~sostdc1 gene~|~sostdc1 wt allele~|~specific qualifier value~|~to specify~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~determined by
syncope~|~alcohol consumption~|~specific qualifier value~|~changed status~|~changing~|~in addition to~|~intoxication~|~mental status change~|~mental status, ctcae~|~mental state~|~mental status:finding:point in time:^patient:narrative:observed~|~mental status:finding:point in time:^patient:nominal:observed~|~nr4a2 gene~|~negation~|~not otherwise specified~|~with - dosing instruction fragment
nurse administrator~|~pain~|~diazooxonorleucine~|~facial injuries~|~fingers~|~hand~|~priests~|~killing~|~andorra~|~multiple trauma~|~and~|~and - dosing instruction fragment~|~entire hand~|~fingers, unit of measurement~|~not otherwise specified~|~relationshipconjunction - and~|~to specify~|~traumatic injury~|~hand - unit of measure~|~administration method - pain~|~adverse event associated with pain~|~feel pain~|~frequency of pain question~|~have pain~|~how much distress pain~|~pain distress question~|~pain by anatomic descriptor, ctcae~|~pain, ctcae~|~pain:-:point in time:^patient:-~|~sacrifice~|~usual severity pain~|~kill - actrelationshipjoin
hyperglycemia~|~diabetes mellitus~|~specific qualifier value~|~glucose in blood specimen above reference range~|~hyperglycemia, ctcae~|~diabetes~|~in addition to~|~not otherwise specified~|~with - dosing instruction fragment~|~abdominal tenderness~|~generalized aches and pains~|~nausea and vomiting
cerebral infarction~|~migraine disorders~|~nausea~|~primary thunderclap headache~|~bothered by nausea~|~external cause codes: unspecified~|~feel nausea~|~have nausea~|~how much distress nausea~|~how much nausea during this period~|~how often nausea~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~specific qualifier value~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~usual severity nausea
angina pectoris~|~chest pain~|~vomiting~|~external cause codes: unspecified~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~bothered by vomiting~|~chest pain:finding:point in time:^patient:ordinal~|~have been vomiting~|~how much distress vomiting~|~how often vomiting~|~usual severity vomiting~|~vomiting, ctcae
anxiety~|~chest pain~|~anxiety disorders~|~anxiety scale (basc-2)~|~anxiety visual analogue scale~|~anxiety, ctcae 3.0~|~anxiety, ctcae 5.0~|~not otherwise specified~|~external cause codes: unspecified~|~finding of cardiac pacemaker~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~chest pain:finding:point in time:^patient:ordinal
back pain~|~caucasoid race~|~generalized abdominal pain~|~signs and symptoms~|~cough frequency~|~cough, ctcae~|~coughing~|~have been coughing~|~how much distress cough~|~nr4a2 gene~|~negation~|~specific qualifier value~|~usual severity cough~|~back pain, ctcae 3.0~|~back pain, ctcae 5.0~|~caucasians~|~generalized aches and pains~|~white color
mental orientation~|~pulmonary edema~|~nr4a2 gene~|~negation~|~cdisc adas-cog - orientation summary score~|~changed status~|~changing~|~external cause codes: unspecified~|~genomic orientation~|~good~|~localized edema~|~localized edema, ctcae~|~mental status change~|~mental status, ctcae~|~mental state~|~mental status:finding:point in time:^patient:narrative:observed~|~mental status:finding:point in time:^patient:nominal:observed~|~microplate well~|~montreal cognitive assessment orientation test~|~orientation (spatial)~|~pulmonary edema, ctcae~|~specific qualifier value~|~this (eukaryote)~|~to specify~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~usual~|~usually~|~well~|~well marginated nodule
wiskott-aldrich syndrome~|~nausea~|~was protein, human~|~vomiting~|~bothered by nausea~|~feel nausea~|~have nausea~|~how much distress nausea~|~how much nausea during this period~|~how often nausea~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~usual severity nausea~|~was gene~|~washoe language~|~bothered by vomiting~|~have been vomiting~|~how much distress vomiting~|~how often vomiting~|~usual severity vomiting~|~vomiting, ctcae
syncope~|~tachycardia~|~cardiac arrhythmia~|~adverse event associated with cardiac arrhythmia~|~specific qualifier value
asthma~|~dyspnea~|~change -- procedure~|~changed status~|~changing~|~delta (difference)~|~dyspnea, ctcae~|~external cause codes: unspecified~|~in addition to~|~mental status, ctcae~|~mental state~|~mental status:finding:point in time:^patient:narrative:observed~|~mental status:finding:point in time:^patient:nominal:observed~|~much~|~nr4a2 gene~|~negation~|~specific qualifier value~|~toxic effect of unspecified substance~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~with - dosing instruction fragment~|~exacerbation acute
poisoning~|~andorra~|~hypotension~|~pharmaceutical preparations~|~specific qualifier value~|~and~|~and - dosing instruction fragment~|~biological factors~|~drugs - dental services~|~external cause codes: unspecified~|~good~|~hypotension, ctcae~|~indeterminate~|~mental status change~|~microplate well~|~nr4a2 gene~|~negation~|~relationshipconjunction - and~|~suicide attempt incident code~|~suicide attempt, ctcae~|~suicide attempt~|~undetermined~|~undetermined finding~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~well~|~well marginated nodule
chest pain~|~hypertensive disease~|~ever told by doctor or nurse that you have high blood pressure:finding:point in time:^patient:ordinal~|~chest pain:finding:point in time:^patient:ordinal
abdominal pain~|~generalized aches and pains~|~allergy severity - severe~|~borg category-ratio 10 perceived exertion score 5~|~epidermal cgvhd score 4~|~grade 3 severe adverse event~|~in addition to~|~intensity and distress 5~|~nr4a2 gene~|~negation~|~severe (severity modifier)~|~severe - severity of illness code~|~severe - triage code~|~severe extremity pain~|~severe hallucination~|~specific qualifier value~|~usual~|~usually~|~with - dosing instruction fragment~|~abdominal pain, ctcae 5~|~abdominal rigidity~|~generalized abdominal pain
wiskott-aldrich syndrome~|~sepsis~|~septicemia~|~was protein, human~|~chronic obstructive airway disease~|~andorra~|~acute - triage code~|~admission level of care code - acute~|~and~|~and - dosing instruction fragment~|~lower respiratory tract infection~|~relationshipconjunction - and~|~sepsis (invertebrate)~|~sepsis, ctcae~|~specific qualifier value~|~was gene~|~washoe language~|~acute~|~acute inpatient encounter
cerebral infarction~|~diabetes mellitus~|~fascia~|~festivals~|~hyperglycemia~|~abnormal coordination~|~entire fascia~|~external cause codes: unspecified~|~glucose in blood specimen above reference range~|~home environment~|~house (environment)~|~hyperglycemia, ctcae~|~in addition to~|~specific qualifier value~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~with - dosing instruction fragment
sepsis~|~nervousness~|~septicemia~|~external cause codes: unspecified~|~feeling nervous~|~good~|~microplate well~|~nr4a2 gene~|~negation~|~old age~|~organism~|~senility~|~senior - suffix~|~sepsis (invertebrate)~|~sepsis, ctcae~|~specific qualifier value~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~well~|~well marginated nodule~|~senescence function
dyspnea~|~asthma~|~pneumonia~|~united arab emirates~|~have shortness of breath question~|~how much distress shortness of breath~|~how often shortness of breath~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~usual severity shortness of breath~|~androgen response element~|~in addition to~|~organism~|~specific qualifier value~|~with - dosing instruction fragment~|~are unit of measure~|~exacerbation acute
vision~|~nurse administrator~|~diazooxonorleucine~|~traumatic injury~|~side~|~to specify~|~traumatic and/or non-traumatic injury~|~unspecified injury of elbow
seizures~|~conduct disorder~|~nr4a2 gene~|~negation~|~specific qualifier value~|~fecal immunochemical test~|~fit (action)~|~fit and well~|~prosthesis fit~|~data table~|~distal (qualifier value)~|~good~|~mental status change~|~microplate well~|~singular~|~table - furniture~|~well~|~well marginated nodule~|~housewife~|~aggressive behavior~|~aggressive course~|~entity risk - aggressive~|~precaution code - aggressive~|~risk codes - aggressive
apnea~|~apnea, ctcae~|~nr4a2 gene~|~negation~|~sostdc1 gene~|~sostdc1 wt allele~|~specific qualifier value
dyspnea~|~caucasoid race~|~chronic obstructive airway disease~|~nr4a2 gene~|~negation~|~senior - suffix~|~dyspnea, ctcae~|~external cause codes: unspecified~|~in addition to~|~much~|~specific qualifier value~|~to specify~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~with - dosing instruction fragment~|~worried~|~exacerbation acute~|~caucasians~|~white color
asthma~|~hyaline membrane disease~|~sambucus~|~dyspnea~|~asphyxia~|~respiratory distress syndrome, adult~|~wheezing~|~foreign bodies~|~trachea~|~tracheal diseases~|~asthma pathway~|~causing~|~entire trachea~|~have shortness of breath question~|~how much distress shortness of breath~|~how often shortness of breath~|~in addition to~|~shortness of breath visual analogue scale~|~shortness of breath:-:point in time:^patient:-~|~trachea (moth)~|~usual severity shortness of breath~|~with - dosing instruction fragment~|~elder extract~|~exacerbation acute~|~wheezing, ctcae
anxiety~|~anxiety disorders~|~anxiety scale (basc-2)~|~anxiety visual analogue scale~|~anxiety, ctcae 3.0~|~anxiety, ctcae 5.0~|~not otherwise specified
wiskott-aldrich syndrome~|~was protein, human~|~diarrhea~|~fever~|~chills~|~was gene~|~washoe language~|~chills, ctcae~|~diarrhea, ctcae~|~external cause codes: unspecified~|~have diarrhea~|~how much distress diarrhea~|~how often diarrhea~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~usual severity diarrhea~|~fever symptoms (finding)~|~fever with chills~|~fever, ctcae
cerebral infarction~|~transient ischemic attack~|~external cause codes: unspecified~|~good~|~mental status change~|~microplate well~|~nr4a2 gene~|~negation~|~specific qualifier value~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~well~|~well marginated nodule~|~elevated blood-pressure reading without diagnosis of hypertension~|~transient hypertension
poisoning~|~craniocerebral trauma~|~alcohol consumption~|~andorra~|~external cause codes: unspecified~|~pharmaceutical preparations~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~and~|~and - dosing instruction fragment~|~biological factors~|~drugs - dental services~|~in addition to~|~indeterminate~|~intoxication~|~relationshipconjunction - and~|~undetermined~|~undetermined finding~|~with - dosing instruction fragment
headache~|~face~|~physical examination~|~headache, ctcae~|~nr4a2 gene~|~negation~|~specific qualifier value~|~diagnosis~|~chief complaint (finding)~|~diagnosis classification - diagnosis~|~diagnosis code~|~diagnosis study~|~diagnosis:impression/interpretation of study:point in time:^patient:nominal~|~elovl6 gene~|~encounter~|~entire face~|~examination~|~fance wt allele~|~fanconi anemia, complementation group e~|~face (spatial concept)~|~facilitated oscillatory release technique~|~good~|~healthcare encounter~|~medical examination~|~microplate well~|~patient visit~|~preposition for~|~report (document)~|~reported~|~reporting~|~suspected diagnosis~|~suspected qualifier~|~visit~|~wwox gene~|~wwox wt allele~|~well~|~well marginated nodule~|~without~|~diagnosis aspect~|~general medical service~|~generalized~|~generalized aches and pains~|~safety reporting documentation~|~united states military commissioned officer o10
wiskott-aldrich syndrome~|~hyaline membrane disease~|~was protein, human~|~chills~|~signs and symptoms~|~cdisc sdtm adverse event outcome terminology~|~chills, ctcae~|~cough with fever~|~out (direction)~|~removed~|~result~|~tcf23 gene~|~was gene~|~washoe language~|~general symptom
seizures~|~epileptic syndromes~|~andorra~|~and~|~and - dosing instruction fragment~|~channel~|~channel object~|~fecal immunochemical test~|~fit (action)~|~fit and well~|~nr4a2 gene~|~negation~|~prosthesis fit~|~relationshipconjunction - and~|~sostdc1 gene~|~sostdc1 wt allele~|~specific qualifier value~|~idiopathic epilepsy
chronic obstructive airway disease
hematopoiesis~|~vomiting~|~hemorrhage~|~nr4a2 gene~|~negation~|~specific qualifier value~|~external cause codes: unspecified~|~much~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~housewife~|~bothered by vomiting~|~have been vomiting~|~how much distress vomiting~|~how often vomiting~|~intestinal hemorrhage nos~|~lower gastrointestinal hemorrhage~|~usual severity vomiting~|~vomiting, ctcae
nausea~|~andorra~|~anxiety~|~disease~|~shock~|~anxiety disorders~|~emotions~|~signs and symptoms~|~and~|~and - dosing instruction fragment~|~anxiety scale (basc-2)~|~anxiety visual analogue scale~|~anxiety, ctcae 3.0~|~anxiety, ctcae 5.0~|~bothered by nausea~|~external cause codes: unspecified~|~feel nausea~|~geographic state~|~have nausea~|~how much distress nausea~|~how much nausea during this period~|~how often nausea~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~now (cigarettes)~|~now (temporal qualifier)~|~now - dosing instruction fragment~|~psychoactive substance~|~relationshipconjunction - and~|~restlessness and agitation~|~specific qualifier value~|~state~|~state ownership~|~stress~|~stress bismuth subsalicylate~|~us state~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~usual severity nausea~|~w stress~|~definitely related to intervention~|~general symptom~|~pelvic and perineal pain~|~relate - vinyl resin~|~related personal status~|~relationships~|~role link type - related
dizziness~|~alcohol abuse~|~lightheadedness~|~behavior showing increased motor activity~|~alcohol abuse scale (basc-2)~|~overactivity~|~uncomplicated~|~worried
poisoning~|~personnel selection~|~indeterminate~|~undetermined~|~undetermined finding~|~irritability and anger
facial injuries~|~falls~|~falling injury~|~generalized~|~not otherwise specified~|~tendency to fall
wiskott-aldrich syndrome~|~was protein, human~|~fever~|~chills~|~chills, ctcae~|~was gene~|~washoe language~|~fever symptoms (finding)~|~fever, ctcae
syncope~|~wiskott-aldrich syndrome~|~chest pain~|~nausea~|~was protein, human~|~vomiting~|~bothered by nausea~|~external cause codes: unspecified~|~feel nausea~|~have nausea~|~how much distress nausea~|~how much nausea during this period~|~how often nausea~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~usual severity nausea~|~was gene~|~washoe language~|~bothered by vomiting~|~chest pain:finding:point in time:^patient:ordinal~|~have been vomiting~|~how much distress vomiting~|~how often vomiting~|~usual severity vomiting~|~vomiting, ctcae
hypoglycemia~|~hypoxemia~|~specific qualifier value~|~hypoglycemia, ctcae~|~mental status change~|~much~|~nr4a2 gene~|~negation
acute lymphocytic leukemia~|~precursor cell lymphoblastic leukemia lymphoma~|~chest pain~|~bcr protein, human~|~thoracic injuries~|~all~|~bcr gene~|~bcr wt allele~|~encounter~|~firstly~|~healthcare encounter~|~initial (abbreviation)~|~initial adverse event and product problem report~|~initial usage~|~initially~|~patient visit~|~universal restriction modifier (core metadata concept)~|~visit~|~all - localmarkupignore~|~all - tablerules~|~acute pain due to trauma~|~chest pain:finding:point in time:^patient:ordinal~|~pain of right shoulder joint
nausea~|~neck injuries~|~bothered by nausea~|~encounter~|~external cause codes: unspecified~|~feel nausea~|~firstly~|~have nausea~|~healthcare encounter~|~how much distress nausea~|~how much nausea during this period~|~how often nausea~|~initial (abbreviation)~|~initial adverse event and product problem report~|~initial usage~|~initially~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~patient visit~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~usual severity nausea~|~visit~|~ever told by doctor or nurse that you have high blood pressure:finding:point in time:^patient:ordinal~|~hypertensive disease~|~secondary hypertension
hypotension~|~hypovolemia~|~nr4a2 gene~|~negation~|~specific qualifier value~|~skin~|~climbing~|~does climb~|~entire skin~|~hypotension, ctcae~|~much~|~senior - suffix~|~skin specimen~|~skin specimen source code~|~skin, human~|~stenia~|~entity determiner - specific
armenia~|~chest pain~|~upper arm~|~andorra~|~upper extremity~|~akr1a1 wt allele~|~aldose reductase m gene~|~armc9 gene~|~and~|~and - dosing instruction fragment~|~axillary reverse mapping~|~entire upper arm~|~entire upper limb~|~protocol treatment arm~|~relationshipconjunction - and~|~sequence arm~|~specific qualifier value~|~to specify~|~chest pain:finding:point in time:^patient:ordinal
chest pain~|~chest pain:finding:point in time:^patient:ordinal~|~acute myocardial infarction~|~nr4a2 gene~|~negation~|~specific qualifier value~|~specify other~|~to specify
wiskott-aldrich syndrome~|~chest pain~|~nausea~|~was protein, human~|~vomiting~|~specific qualifier value~|~chest pain:finding:point in time:^patient:ordinal~|~bothered by nausea~|~else~|~feel nausea~|~have nausea~|~how much distress nausea~|~how much nausea during this period~|~how often nausea~|~nausea subscale~|~nausea visual analogue scale~|~nausea, ctcae 3.0~|~nausea, ctcae 5.0~|~nausea:presence or threshold:point in time:^patient:ordinal~|~usual severity nausea~|~was gene~|~washoe language~|~bothered by vomiting~|~have been vomiting~|~how much distress vomiting~|~how often vomiting~|~usual severity vomiting~|~vomiting, ctcae
andorra~|~and~|~and - dosing instruction fragment~|~external cause codes: unspecified~|~fbn1 gene~|~fbn1 wt allele~|~mass of body region~|~mass of body structure~|~mass of skin~|~mass, a measure of quantity of matter~|~molecular mass~|~morphology, attenuation, size, and structure criteria~|~much~|~nr4a2 gene~|~negation~|~relationshipconjunction - and~|~skin and subcutaneous tissue structure~|~specific qualifier value~|~specimen source codes - mass~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~abdominal tenderness~|~generalized abdominal pain~|~localized pain~|~localized swelling
syncope~|~allergic reaction~|~allergy specialty~|~genetic carriers~|~vomiting~|~external cause codes: unspecified~|~unspecified~|~unspecified - name type~|~unspecified state of consciousness~|~hypersensitivity~|~allergic disposition~|~allergy - charge type reason~|~carrier device~|~carrier of disorder~|~change -- procedure~|~changed status~|~changing~|~delta (difference)~|~mental status, ctcae~|~mental state~|~mental status:finding:point in time:^patient:narrative:observed~|~mental status:finding:point in time:^patient:nominal:observed~|~not otherwise specified~|~reprint carrier~|~response to antigens~|~small-molecule carrier or transporter~|~bothered by vomiting~|~have been vomiting~|~how much distress vomiting~|~how often vomiting~|~usual severity vomiting~|~vomiting, ctcae
disease~|~psychotic disorders~|~fatigue~|~nr4a2 gene~|~negation~|~condition~|~condition domain~|~condition:find:pt:^patient:nom~|~due to~|~logical condition~|~mental disorders~|~much~|~not otherwise specified~|~physiological~|~specific qualifier value~|~strange and inexplicable behavior~|~substance~|~fatigue subordinate domain~|~fatigue, ctcae 5.0~|~feel fatigue